about
Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA).Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascitesRandomized clinical trial of vertical or transverse laparotomy for abdominal aortic aneurysm repair.Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus.Relationship Between FEV1 and Patient-Reported Outcomes Changes: Results of a Meta-Analysis of Randomized Trials in Stable COPD.Effectiveness of alitretinoin in severe chronic hand eczema: PASSION, a real-world observational study.Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA).Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA).Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigs.Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritis.Assumed oxygen consumption frequently results in large errors in the determination of cardiac output.[MS registry in Germany--design and first results of the pilot phase].Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA).Cardiac index monitoring by pulse contour analysis and thermodilution after pediatric cardiac surgery.Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension.Cardiac output determination in children: equivalence of the transpulmonary thermodilution method to the direct Fick principle.Blood-pressure-lowering effect of carvedilol vs nitrendipine in geriatric hypertensivesUltrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter-related infections in patients with haemato-oncological diseases: a prospective observational studyCreatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical studyMale factors determining the outcome of intracytoplasmic sperm injection with epididymal and testicular spermatozoa[Contrast medium-induced renal failure can not be prevented by hemodialysis]Immunomonitoring results of a phase II/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3)A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgarisThe role of relative lymphocyte count as a biomarker for the effect of catumaxomab on survival in malignant ascites patients: results from a phase II/III study
P50
Q30664233-E0580E5C-5B7E-490C-B2F1-D518C19047BCQ31987891-BA026AA1-65AE-442C-BCCE-9F761BD7FDCCQ36153347-30C9817A-F995-41C2-80AF-4AED782F1269Q36263202-C4A90B86-49F6-4122-8CD7-4A68FCEFCC84Q36484244-5D599408-DE6F-4870-A739-08FCCEC36ADBQ36615060-F612A5F1-7E74-4734-805F-3E0CFC596D81Q37612679-BE038AE5-1807-490C-8CCC-22E2ECB97C5DQ38433514-DF2998C0-9C5C-4D77-8163-8AEEAA217CAFQ38604644-4D10B6A3-B0BF-412F-B627-AAFB4ED1D4DEQ40585781-51AFFD93-ACAC-43D6-A582-7F7BA65D45F3Q44009373-AE9C9AB5-EC48-403D-A7B7-8AFF5EEA62ECQ44062389-7D1D2E02-B1BA-4406-8757-13629E3A4D6DQ44913739-495D4404-F817-42EF-B6EE-FAABA540F06FQ45183282-8D113111-3898-40FA-A69A-8B87B401834EQ46440692-D44828F5-C75B-4916-91FE-A3C5877A7BBDQ47808722-DB37D47A-03C8-4171-B04B-96CF0B74F4D0Q48798412-3AAA0E3A-D1EC-4D2D-8684-17C583ABE720Q50231895-D5B6D46B-4724-4B5A-821D-6AA64B4F95ECQ50657181-68BD48D5-E322-46AC-BF25-02DB5C07D806Q51089398-DD611B61-DEEA-46C3-87AF-E878F20F79C9Q51483001-FA1B9DDC-22FD-4309-BD21-B969C3F498D3Q52036526-BCDE1D3B-7862-4F9A-86E9-C0F01C7A5E65Q68093345-C08569C9-8ABF-4C24-964D-79E115CEAA04Q73152600-C7324491-DB21-4365-A6C6-1C3E03143252Q73766458-64DF86DE-2B7B-49E1-9D3F-A56F322187CFQ73888584-90AC5F58-0859-4942-9B3D-AA8E8EB28F89Q77796216-36B2DE36-BBF6-4608-B56A-C5A0B9E79CDCQ82294993-315DC4D8-0C0B-4805-9792-58A81B166980Q87369580-73102E96-50DE-4234-8D38-E8530FDBA987Q87641174-9A20AAB9-8B9C-4418-9C2F-36BBD199C645
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
M Hennig
@ast
M Hennig
@en
M Hennig
@es
M Hennig
@nl
type
label
M Hennig
@ast
M Hennig
@en
M Hennig
@es
M Hennig
@nl
prefLabel
M Hennig
@ast
M Hennig
@en
M Hennig
@es
M Hennig
@nl
P31
P496
0000-0001-5318-4788